Fairvalue-Calculator Fairvalue-Calculator
EN DE

P3 Health Partners Inc (PIII) Fair Value & Analysis

Healthcare · US · Market cap $2.2B

Price$11.31
Fair Value$26.44
Upside+133.8%
Quality92/100
Evidence: Low Range $19.83 – $33.05

Fair value as of: Jun 23, 2026

Analysis

P3 Health Partners Inc (PIII) currently trades at $11.31, while our model-based Fair Value estimate is $26.44 — implying the stock looks roughly 133.8% undervalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) -74% Fresenius SE (FSNUY) -27% 5225 (5225) -64% IHHHF (IHHHF) -57% Tenet Healthcare Corporation (THC) +70% Rede D'Or São Luiz S.A (RDOR3) +42%

Frequently asked questions

Is P3 Health Partners Inc (PIII) undervalued?
As of Jun 23, 2026, our model estimates a fair value of $26.44 versus a price of $11.31 — about +134% (undervalued). Model-based estimate, not financial advice.
What is the fair value of PIII?
Our 21-model fair value for P3 Health Partners Inc is $26.44 (as of Jun 23, 2026), built from audited fundamentals. The current price is $11.31.
What is the quality score of PIII?
P3 Health Partners Inc has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.